Founder's components: TGFB1-3, TGFBR1/2, SMAD2/3/4.
DRY status
DRY: none located. No dry-fast study measured TGFB1-3, TGFBR1/2 or SMAD2/3/4. Queries run: the four DRY queries under node 1, plus "fasting TGF-beta1 human serum myostatin SMAD2/3 skeletal muscle fasting", "Ramadan fasting TGF-beta1 serum human study immune cytokine", "intermittent fasting TGF-beta SMAD3 kidney fibrosis mouse improvement study". Empty for DRY.
Disconfirming, nulls and contradictions first
- The direction of the human evidence on this node is NO CHANGE. Larsen et al. 2006, 40 hour fast, n=6, vastus lateralis biopsies at 3, 15 and 40 h plus plasma ELISA: myostatin, a TGF-β superfamily ligand, was unchanged at the gene level AND in plasma. Atrogin-1 and MuRF-1 were also unchanged. The authors concluded that, unlike catabolic and cachectic states, a 40 hour fast does not markedly alter these genes, and suggested longer fasts may be needed. [PF, H3, grade C]
- A second human fast corroborates the muscle-atrophy null at 72 hours. Vendelbo et al. 2014, 72 hour fast, n=8: MAFbx and MURF1 unchanged, even though mTOR signaling fell by about half in the same biopsies. Two independent human fasts, at 40 h and 72 h, both null on the atrogenic arm. [PF, H3, grade C]
- No human or animal fasting study located measured SMAD2, SMAD3 or SMAD4 phosphorylation, or TGFBR1 or TGFBR2. The SMAD arm of this node is entirely unmeasured under fasting. [M, grade C]
- The one positive human transcript is FDR-null. Elliott et al. 2014, 36 h fast: LTBP1, latent transforming growth factor beta binding protein 1, up +1.49 at nominal p < 0.05, in a gene list where the authors state no gene would be considered significantly affected under FDR < 5 percent. The paper discusses TGF-β only in reference to other studies, not as its own finding. [H3, grade C]
- The most suggestive human fasting result on this node is an INFERENCE and is labeled one. Pietzner et al. 2024, 7-day water-only fast, n=12: the plasma proteome signature was strongly enriched for extracellular matrix proteins from multiple body sites. Extracellular-matrix production is a canonical TGF-β output on the founder's own node description. TGF-β itself was not measured in that study. The hop is: ECM proteins changed, therefore a TGF-β-regulated output changed, therefore the node may be engaged. Two hops, no measurement of the node. Written as M. [M, grade C]
Graded rows
| # | Modality | System | Tier | Grade | Finding | Source |
|---|---|---|---|---|---|---|
| 8.1 | PF (40 h) | Human skeletal muscle, n=6, biopsies at 3, 15, 40 h | H3 | C | Myostatin gene expression unchanged and plasma myostatin unchanged. Atrogin-1 and MuRF-1 unchanged. myoD, myogenin and Myf5 unchanged. Plasma IGF-1 unchanged. NULL. No fold changes or p-values retrieved. | Larsen et al. 2006, Ann Nutr Metab 50(5):476-481, PMID 16931880, DOI 10.1159/000095354 |
| 8.2 | PF (72 h) | Human skeletal muscle, n=8 men, crossover | H3 | C | MAFbx and MURF1 unchanged after a 72 h fast, in the same biopsies where mTOR phosphorylation fell about 50 percent. Independent corroboration of the atrogenic null at a longer duration. | Vendelbo et al. 2014, PLoS ONE 9(7):e102031, PMID 25020061, DOI 10.1371/journal.pone.0102031 |
| 8.3 | PF (36 h) | Human PBMC, n=10 | H3 | C | LTBP1 up +1.49 at nominal p < 0.05. NO GENE IN THIS STUDY SURVIVED FDR < 5 PERCENT, by the authors' own statement. No TGF-β or SMAD measured. | Elliott et al. 2014, Genes Nutr 9:432, DOI 10.1007/s12263-014-0432-4 |
| 8.4 | PF (7 d, water only) | Human plasma, n=12 | M | C | More than 1,000 of about 3,000 plasma proteins responded; the signature was strongly enriched for extracellular matrix proteins from multiple body sites, including the brain-specific ECM protein tenascin-R. Systemic change evident only after 3 days. TGF-β AND SMAD WERE NOT MEASURED. The link to this node is inferred through ECM output, hops shown above. | Pietzner et al. 2024, Nat Metab 6(4):764-777, PMID 38429390, DOI 10.1038/s42255-024-01008-9 |
Open questions
- Both human nulls ran at 40 h and 72 h. Pietzner et al. show nothing systemic moves until day 3 of a water-only fast, and Larsen et al. themselves suggested longer fasts may be required. The nulls are therefore nulls at those durations and say nothing about 5 to 10 day protocols, where no measurement of this node exists.
- Whether the 7-day ECM enrichment is TGF-β mediated is open and currently unmeasurable from the retrieved record. It is the clearest closable gap in this node.
← 7. Hippo All 41 nodes 9. NF-κB →
dryfasting.com has been published since 2014. This evidence record was compiled on 22 November 2026. Every row names the fasting modality the study actually ran, the system it was measured in and the grade. Where no source carries a DOI or PMID the row says so rather than supplying one. Nothing is sold on this site.